These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12604558)

  • 21. Susceptibilities of 428 gram-positive and -negative anaerobic bacteria to Bay y3118 compared with their susceptibilities to ciprofloxacin, clindamycin, metronidazole, piperacillin, piperacillin-tazobactam, and cefoxitin.
    Pankuch GA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1649-54. PubMed ID: 8215278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of in vitro activity of teicoplanin against recent clinical isolates.
    Nani E; Amato G; Anzivino D; Covelli B; Lembo M
    Chemioterapia; 1988 Feb; 7(1):20-3. PubMed ID: 2967737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activity of WY-49605 compared with those of amoxicillin, amoxicillin-clavulanate, imipenem, ciprofloxacin, cefaclor, cefpodoxime, cefuroxime, clindamycin, and metronidazole against 384 anaerobic bacteria.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2599-604. PubMed ID: 7872754
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the in vitro activity of ertapenem and nine other comparator agents against 337 anaerobic bacteria.
    Behra-Miellet J; Dubreuil L; Calvet L
    Int J Antimicrob Agents; 2006 Jul; 28(1):25-35. PubMed ID: 16757152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activities of daptomycin, vancomycin, quinupristin- dalfopristin, linezolid, and five other antimicrobials against 307 gram-positive anaerobic and 31 Corynebacterium clinical isolates.
    Goldstein EJ; Citron DM; Merriam CV; Warren YA; Tyrrell KL; Fernandez HT
    Antimicrob Agents Chemother; 2003 Jan; 47(1):337-41. PubMed ID: 12499210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In Vitro and In Vivo Activities of a Bi-Aryl Oxazolidinone, RBx 11760, against Gram-Positive Bacteria.
    Barman TK; Kumar M; Mathur T; Chaira T; Ramkumar G; Kalia V; Rao M; Pandya M; Yadav AS; Das B; Upadhyay DJ; Hamidullah ; Konwar R; Raj VS; Singh H
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7134-7145. PubMed ID: 27645240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activities of linezolid against important gram-positive bacterial pathogens including vancomycin-resistant enterococci.
    Noskin GA; Siddiqui F; Stosor V; Hacek D; Peterson LR
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2059-62. PubMed ID: 10428937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones.
    Jones RN; Johnson DM; Erwin ME
    Antimicrob Agents Chemother; 1996 Mar; 40(3):720-6. PubMed ID: 8851600
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activities of dalbavancin and nine comparator agents against anaerobic gram-positive species and corynebacteria.
    Goldstein EJ; Citron DM; Merriam CV; Warren Y; Tyrrell K; Fernandez HT
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1968-71. PubMed ID: 12760876
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in-vitro activities of moxifloxacin, trovafloxacin, quinupristin/dalfopristin and linezolid against staphylococci.
    von Eiff C; Peters G
    J Antimicrob Chemother; 1999 Apr; 43(4):569-73. PubMed ID: 10350389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro activity of imipenem against gram-positive anaerobic bacteria.
    Dubreuil L; Devos J; Romond C
    Int J Clin Pharmacol Res; 1987; 7(1):39-43. PubMed ID: 3473047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The in-vitro activity of bicozamycin against anaerobic bacteria of clinical interest.
    Watt B; Brown FV
    J Antimicrob Chemother; 1983 Dec; 12(6):549-53. PubMed ID: 6662834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Time-kill studies of the antianaerobe activity of garenoxacin compared with those of nine other agents.
    Credito KL; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1399-402. PubMed ID: 12654677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Susceptibility of 539 gram-positive and gram-negative anaerobes to new agents, including RP59500, biapenem, trospectomycin and piperacillin/tazobactam.
    Appelbaum PC; Spangler SK; Jacobs MR
    J Antimicrob Chemother; 1993 Aug; 32(2):223-31. PubMed ID: 8226424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antianaerobic activity of the ketolide RU 64004 compared to activities of four macrolides, five beta-lactams, clindamycin, and metronidazole.
    Ednie LM; Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1997 May; 41(5):1037-41. PubMed ID: 9145865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro activity of the tribactam GV104326 against gram-positive, gram-negative, and anaerobic bacteria.
    Di Modugno E; Erbetti I; Ferrari L; Galassi G; Hammond SM; Xerri L
    Antimicrob Agents Chemother; 1994 Oct; 38(10):2362-8. PubMed ID: 7840571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.
    Edmiston CE; Krepel CJ; Kehl KS; Seabrook GR; Somberg LB; Almassi GH; Smith TL; Loehrl TA; Brown KR; Lewis BD; Towne JB
    J Antimicrob Chemother; 2005 Nov; 56(5):872-8. PubMed ID: 16186167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Activity of doripenem against anaerobic bacteria].
    Dubreuil L; Neut C; Mahieux S; Muller-Serieys C; Jean-Pierre H; Marchandin H; Soussy CJ; Miara A
    Pathol Biol (Paris); 2011 Apr; 59(2):102-7. PubMed ID: 20537808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative antianaerobic activity of BMS 284756.
    Hoellman DB; Kelly LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):589-92. PubMed ID: 11158759
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chapter 1-1. Anaerobic infections (General): epidemiology of anaerobic infections.
    ;
    J Infect Chemother; 2011 Jul; 17 Suppl 1():4-12. PubMed ID: 21728084
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.